From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC), accounting for 90% of all pancreatic tumors, is a highly devastating disease with poor prognosis and rising incidence. The lack of available specific diagnostics tests and the limited treatment opportunities contribute to this pejorative issue. Over the last...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Mol Sci
Main Authors: Montemagno, Christopher, Cassim, Shamir, Pouyssegur, Jacques, Broisat, Alexis, Pagès, Gilles
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312874/
https://ncbi.nlm.nih.gov/pubmed/32517181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21114067
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker